These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27939925)

  • 1. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Carrasquillo MM; Allen M; Burgess JD; Wang X; Strickland SL; Aryal S; Siuda J; Kachadoorian ML; Medway C; Younkin CS; Nair A; Wang C; Chanana P; Serie D; Nguyen T; Lincoln S; Malphrus KG; Morgan K; Golde TE; Price ND; White CC; De Jager PL; Bennett DA; Asmann YW; Crook JE; Petersen RC; Graff-Radford NR; Dickson DW; Younkin SG; Ertekin-Taner N
    Alzheimers Dement; 2017 Jun; 13(6):663-673. PubMed ID: 27939925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set.
    Ghani M; Sato C; Kakhki EG; Gibbs JR; Traynor B; St George-Hyslop P; Rogaeva E
    Neurobiol Aging; 2016 Jun; 42():217.e7-217.e13. PubMed ID: 27084067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 regulates innate immunity in Alzheimer's disease.
    Li JT; Zhang Y
    J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREMs in Alzheimer's disease: Genetic and clinical investigations.
    Cheng J; Guo X; Zhang T; Zhong L; Bu G; Chen X
    Clin Chim Acta; 2016 Dec; 463():88-95. PubMed ID: 27769848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
    Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
    JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.
    Sirkis DW; Bonham LW; Aparicio RE; Geier EG; Ramos EM; Wang Q; Karydas A; Miller ZA; Miller BL; Coppola G; Yokoyama JS
    Acta Neuropathol Commun; 2016 Sep; 4(1):98. PubMed ID: 27589997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.
    Song W; Hooli B; Mullin K; Jin SC; Cella M; Ulland TK; Wang Y; Tanzi RE; Colonna M
    Alzheimers Dement; 2017 Apr; 13(4):381-387. PubMed ID: 27520774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 and the Progression of Alzheimer's Disease.
    Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
    Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 variants in Alzheimer's disease.
    Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
    N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coding variants in TREM2 increase risk for Alzheimer's disease.
    Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
    Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore.
    Gussago C; Casati M; Ferri E; Arosio B
    J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Candidate Regulatory Variant at the
    Tian ML; Ni XN; Li JQ; Tan CC; Cao XP; Tan L;
    Front Neurosci; 2019; 13():742. PubMed ID: 31379492
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus.
    Celarain N; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Larumbe R; Pulido L; Echavarri C; Mendioroz M
    Clin Epigenetics; 2016; 8():37. PubMed ID: 27051467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
    Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.
    Winfree RL; Nolan E; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Seto M; Petyuk VA; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ;
    Mol Neurodegener; 2024 May; 19(1):41. PubMed ID: 38760857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Deming Y; Filipello F; Cignarella F; Cantoni C; Hsu S; Mikesell R; Li Z; Del-Aguila JL; Dube U; Farias FG; Bradley J; Budde J; Ibanez L; Fernandez MV; Blennow K; Zetterberg H; Heslegrave A; Johansson PM; Svensson J; Nellgård B; Lleo A; Alcolea D; Clarimon J; Rami L; Molinuevo JL; Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Ewers M; Harari O; Haass C; Brett TJ; Benitez BA; Karch CM; Piccio L; Cruchaga C
    Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.